Phillip E. Lee - 17 Mar 2023 Form 4/A - Amendment Insider Report for Vaxart, Inc. (VXRT)

Role
Chief Financial Officer
Signature
/s/ Edward Berg, Attorney-in-Fact for Phillip Lee
Issuer symbol
VXRT
Transactions as of
17 Mar 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
11 May 2023, 20:33:10 UTC
Date Of Original Report
21 Mar 2023
Previous filing
30 Dec 2022
Next filing
14 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VXRT Common Stock Award $0 +45,000 +65% $0.000000 113,750 17 Mar 2023 Direct F1
transaction VXRT Common Stock Award $0 +56,652 +50% $0.000000 170,402 17 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +205,000 $0.000000 205,000 17 Mar 2023 Common Stock 205,000 $0.7800 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to remove the grant of 90,000 shares of common stock that appeared in Table I, and to remove footnote 3 previously included on the Form 4 filed on March 21, 2023, due to an administrative error. Table I is fully restated to reflect the correct number of common stock held by the Reporting Person on March 17, 2023 to be 170,402. This amendment does not otherwise modify any transaction details that were previously reported in Table I on the Form 4.
F2 This amendment is also being filed to remove the grant of 410,000 shares of common stock in the form of stock options incorrectly reported on the Form 4 filed on March 21, 2023, due to an administrative error. Table II is fully restated to reflect the correct number of stock options held by the Reporting Person on March 17, 2023 to be 205,000, and to remove footnote 4 previously included on the Form 4 filed on March 21, 2023, due to an administrative error. This amendment does not otherwise modify any transaction details that were previously reported in Table II on the Form 4.
F3 The shares subject to this stock option shall fully vest on December 8, 2023.

Remarks:

Exhibit 24 - Power of Attorney